Midazolam in a chronic alcoholic who binged, now vomiting with tremors
Short answer: Midazolam is an acceptable, fast-acting benzodiazepine for alcohol withdrawal when the patient can't take oral drugs because of vomiting. It is not the first choice. Diazepam or lorazepam IV are preferred, because midazolam's short action causes breakpoint rebound, and it needs close monitoring.
Why a benzodiazepine
Vomiting plus tremor in a chronic drinker suggests early uncomplicated withdrawal. This is tremulousness, nausea, anxiety, tachycardia and hypertension. It starts hours to 4 or 5 days after the last drink. Harrison's says symptoms begin 5-10 h after intake falls, peak on day 2-3, and settle by day 4-5 (Harrison's Principles of Internal Medicine 22E). Benzodiazepines act on GABA-A receptors to replace the depressant effect of alcohol. They have the best supporting data, with a high level of safety and low cost. They lower the risk of seizures and delirium tremens (about 2% and about 1% of patients with alcohol use disorder, respectively).
Where midazolam fits
- Route and speed: Tintinalli's lists the IV onset as 2-5 min for midazolam, 5 min for diazepam and 5-20 min for lorazepam. IM absorption of midazolam and lorazepam is adequate. IM diazepam is erratic and not recommended. Midazolam is therefore useful when there is no IV access, or in an agitated, vomiting patient who can't take oral drugs (Tintinalli's Emergency Medicine, p. 1266).
- Vomiting: Tintinalli's recommends parenteral treatment, giving diazepam 10-20 mg IV or lorazepam 2-4 mg IV if the patient is vomiting. Midazolam can be used when these aren't available.
- Severe or refractory withdrawal (delirium tremens): Midazolam is used as a titrated bolus or infusion in the ICU. Tintinalli's escalation for benzodiazepine-refractory delirium tremens is phenobarbital or propofol, usually with intubation.
- Seizure with no IV access: IM midazolam is a reasonable option. I'm drawing that from general practice, and the textbook passages I pulled don't cover it.
Drawbacks of midazolam
- Short half-life: Its effect wears off quickly, which causes breakthrough symptoms and fluctuating levels. Harrison's notes that short-half-life agents must be given every 4 h to avoid abrupt level fluctuations that raise seizure risk. Long-acting agents (diazepam, chlordiazepoxide) self-taper. Diazepam and chlordiazepoxide give a 20-30 h effect through active metabolites.
- Liver disease: Chronic drinkers often have impaired hepatic function. Midazolam is cleared by CYP3A4 and can accumulate. Lorazepam, which is conjugated, is safer in significant liver disease. This point is from general pharmacology, not the textbook text I retrieved.
- Respiratory depression and aspiration: Vomiting plus sedation raises aspiration risk, and ongoing alcohol intoxication adds to the depressant effect. Titrate in small doses and monitor SpO2, respiratory rate and mental status. Give benzodiazepines for actual withdrawal signs, not just because the patient drank heavily.
Practical approach
- Assess: vitals, temperature, glucose, electrolytes (K, Mg, phosphate), liver function, and signs of GI bleed, pancreatitis, infection or head injury. Score with CIWA-Ar.
- Give thiamine before glucose, then other B vitamins.
- Avoid routine IV fluids unless vomiting or bleeding has caused real volume loss (Harrison's). Treat the vomiting with an antiemetic such as ondansetron.
- Use symptom-triggered dosing. Tintinalli's guide: CIWA-Ar above 15, repeat hourly until below 15. A score of 8-14 means repeat every 2 h until below 8. Fixed-dose regimens tend to undertreat or overtreat (Washington Manual).
- Choose the drug:
- Vomiting but stable: diazepam IV or lorazepam IV, then switch to oral once vomiting stops.
- Midazolam IV/IM in small titrated doses: when you need fast onset or have no IV access. Convert to a longer-acting agent for maintenance.
- Severe symptoms or delirium tremens: ICU, high-dose benzodiazepines, then phenobarbital or propofol if refractory.
- Avoid dexmedetomidine as a sole agent. It doesn't act on GABA or glutamate, may mask autonomic signs without preventing seizures, and hasn't improved outcomes in trials (Washington Manual).
Recent evidence
Two recent reviews are relevant: a
2026 systematic review and meta-analysis of phenobarbital versus benzodiazepine pathways in critically ill adults (PMID 42634386), and a
2024 network meta-analysis of drug treatments for withdrawal (PMID 38170803). They suggest phenobarbital-based pathways are a growing alternative in ICU care. I only saw the titles and metadata, not the full results, so this doesn't change the recommendation above. Benzodiazepines remain first-line for uncomplicated withdrawal.
Sources: Tintinalli's Emergency Medicine, p. 1266 (Table 185-2, Treatment); Harrison's Principles of Internal Medicine 22E, Alcohol Withdrawal; The Washington Manual of Medical Therapeutics, Alcohol Withdrawal.
Doses and drug choice should follow your local protocol and the patient's liver function and respiratory status.